Semax Nasal Spray: How It’s Used, Benefits and Risks
Semax nasal spray is a Russian-developed nootropic peptide that researchers are testing for migraine, chronic pain and stroke recovery. U.S. access is limited today, but an interim FDA policy now allows 503A compounding when a prescriber writes an individual prescription.
Semax nasal spray is a laboratory-made fragment of adrenocorticotropic hormone (ACTH 4-7) modified with a Pro-Gly-Pro tail. When sprayed into the nose, it is rapidly absorbed through the nasal mucosa and appears to increase brain-derived neurotrophic factor (BDNF) and antioxidant enzymes in animal studies. Doctors in Russia have prescribed it for vision and circulation problems since the 1990s, but in the United States it remains experimental: no FDA-approved product exists, and safety in humans is still largely unknown.
- Semax is a synthetic peptide classified as a nootropic and investigated for neuroprotective effects. (Polunin et al., 2000)
- Russian clinicians deliver semax intranasally because nasal mucosa bypasses the blood-brain barrier more directly than an oral route. (Polunin et al., 2000)
- Small studies have explored semax for optic-nerve injury, retinal surgery recovery, primary open-angle glaucoma, migraine and post-stroke rehabilitation. (Polunin et al., 2000) (Sheludchenko et al., 2026) (Yusef et al., 2026)
- No randomized controlled trials large enough for FDA approval have been completed, so efficacy and long-term safety are unproven. (Vanhee et al., 2020)
- The FDA’s October 2026 interim policy lets state-licensed 503A pharmacies compound semax for individual patients under certain quality and reporting conditions.
What Semax Nasal Spray Is
Semax is a heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Russian scientists designed it to resist breakdown by nasal and blood enzymes, making intranasal delivery feasible. Laboratory work shows the molecule withstands proteolysis better than shorter glyproline fragments in nasal mucus and blood plasma (Shevchenko et al., 2013). Because the nasal route avoids first-pass liver metabolism and may reach the central nervous system more directly, Russian formularies list a 0.1% and 1% nose-drop preparation.
There is no licensed finished drug in the United States. Any use here must rely on a pharmacist compounding semax under a patient-specific prescription.
How Semax May Work in the Brain
Researchers believe semax modulates neurotrophins and antioxidant defenses, which could protect neurons after injury. Animal experiments show higher levels of BDNF, superoxide dismutase and reduced lipid peroxidation after semax administration. These biochemical changes have led investigators to test the peptide for ischemic stroke, chronic ocular ischemia and headache disorders.
Possible mechanisms include: stimulation of melanocortin receptors, inhibition of pro-inflammatory cytokines, and improved microcirculation in cerebral vessels. None of these mechanisms has been definitively proven in large human studies.
What Conditions It’s Being Studied For
Most semax human data come from small Russian trials in ophthalmology and neurology. The table below summarizes the best-documented areas of research.
| Condition | Study size | Delivery method | Main finding |
|---|---|---|---|
| Optic-nerve disease | 3 groups, n = not stated; intranasal vs electrophoresis vs control (Polunin et al., 2000) | Nasal drops or electrophoresis | Faster visual acuity recovery |
| Retinal detachment surgery recovery | 42 patients (23 + 19) (Sheludchenko et al., 2026) | Electrophoresis + Heliox vs nasal drops | Better BCVA and macular sensitivity in combined group |
| Primary open-angle glaucoma post-surgery | 50 patients (64 eyes) (Yusef et al., 2026) | Electrophoresis vs nasal drops | Improved visual field indices at 6 months |
| Migraine prophylaxis | Case series, numbers not published | Nasal drops | Reduced attack frequency (unpublished) |
| Ischemic stroke rehabilitation | Early trials < 100 patients | Nasal drops | Quicker motor recovery (needs confirmation) |
How Commonly Semax Is Used and Where
Semax remains largely confined to Eastern Europe. Russian formularies list the peptide as a prescription-only neuroprotective agent, and Ukrainian and Belarusian neurologists also use it off label. In Western Europe and North America, use is scarce and typically limited to research settings or off-label personal importation. A 2020 forensic analysis found semax and the related peptide selank in seized unapproved sprays sold online, highlighting unregulated availability (Vanhee et al., 2020).
Potential Benefits Researchers Are Investigating
Early data suggest several possible clinical effects, but all need larger trials.
Migraine and chronic pain: Semax’s proposed modulation of trigeminal pathways has fueled small uncontrolled studies for migraine prophylaxis. Reported benefits include fewer headache days, but no blinded comparison exists.
Stroke and neurorehabilitation: Russian stroke protocols sometimes add semax nasal drops within 24 hours of ischemia, based on studies suggesting faster motor recovery and better cognitive scores, though sample sizes are small.
Vision disorders: Evidence is strongest in ocular conditions, where semax added to standard care improved visual field indices after optic-nerve injury and glaucoma surgery (Polunin et al., 2000) (Yusef et al., 2026).
| Outcome Measure | Reported Improvement | Study Reference |
|---|---|---|
| Best-corrected visual acuity (BCVA) | Higher recovery at 12 months | (Sheludchenko et al., 2026) |
| Visual field mean deviation (MD) | From −8.62 dB to −4.33 dB after adjunctive therapy | (Yusef et al., 2026) |
| Optic-nerve conductivity | Increased electric sensitivity | (Polunin et al., 2000) |
Possible Risks and Unknowns
No serious adverse events have been published, but the data are limited. Russian product inserts list mild nasal irritation, transient headache and fatigue. Long-term safety, reproductive toxicity, cancer risk and interactions with other neuroactive drugs remain unstudied.
⚠️ Limited safety monitoring outside Russia
Because semax is not FDA-approved, no mandatory post-marketing surveillance exists in the United States. Any side effects must be reported voluntarily to the prescriber and pharmacy, then filed with FDA’s MedWatch system.
FDA Interim Peptide Policy and 503A Status
On October 16 2026, HHS and FDA issued the “Interim Access Policy for Compounding Using Certain Peptides.” The policy states that, pending further rulemaking, the agency does not intend to take enforcement action against state-licensed 503A pharmacies and physicians who compound semax, BPC-157, TB-500, KPV, MOTS-c or Epitalon for individual patients, as long as pharmacies meet ingredient-quality, manufacturing-standard, labeling and safety-reporting conditions.
The policy does not amount to FDA approval, does not add semax to the 503A bulks list, and states that HHS may reconsider if safety or quality problems emerge. States are not obliged to follow it, so some state boards of pharmacy may still prohibit compounding of semax.
Getting Semax in the United States
Today, legally obtaining semax requires a prescription written by a U.S.-licensed clinician and filled by a compliant 503A pharmacy. Research-chemical vendors advertising “for laboratory use only” products fall outside the FDA policy and offer no purity guarantees.
Rx.com plans to offer prescription compounded versions of these peptides through U.S.-licensed providers and a licensed 503A pharmacy (coming soon). When available, patients will complete an online health intake, and if a provider decides semax could help, the pharmacy will compound and ship the medication. Learn more about future availability at prescription peptides from Rx.com.
For a deeper dive into legal pathways, see our related guide Semax Compounded Access Under the 2026 Policy.
Is a trial of semax nasal spray reasonable for you?
Check the column that fits your situation:
✅ Might proceed
- You have a neurologic or ophthalmic condition that has not responded to standard care
- You understand semax is experimental and benefits are unproven
- You can commit to follow-up visits and side-effect reporting
- You live in a state whose pharmacy board allows peptide compounding
🏥 Talk to a specialist first
- Active pregnancy or breastfeeding (no human safety data)
- History of severe allergic reactions to peptide medications
- Uncontrolled hypertension, heart disease or psychiatric illness
- Participation in another investigational drug trial
- Needle-phobic but considering injectable forms advertised online
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following after using semax nasal spray:
- Severe or persistent headache: could signal intracranial pressure changes
- Nasal bleeding that does not stop: may indicate mucosal injury
- Sudden vision loss or double vision: optic-nerve issues need urgent evaluation
- Severe anxiety, agitation or mood swings: unanticipated neuropsychiatric effect
- Rash, hives or facial swelling: possible allergic reaction to the peptide or preservatives
- Shortness of breath or chest tightness: seek emergency care
- Thoughts of self-harm or suicide: call or text the 988 Suicide & Crisis Lifeline, available 24/7
Scientific References
- Polunin GS, Nurieva SM, Baiandin DL, et al. [Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease]. Vestn Oftalmol. 2000.
- Sheludchenko VM, Matyushchenko AG, Alharki L, et al. [Effect of a combined physiotherapeutic approach on changes in functional parameters after endovitreal surgery of rhegmatogenous retinal detachment with a favorable anatomical outcome]. Vestn Oftalmol. 2026.
- Yusef Y, Sheludchenko VM, Korzhavina AV, et al. [Changes in retinal light sensitivity and morphometry during surgical treatment of primary glaucoma with physiotherapeutic stimulation]. Vestn Oftalmol. 2026.
- Vanhee C, Francotte A, Janvier S, et al. The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: An incentive for controlling agencies to prepare for future encounters of the kind. Drug Test Anal. 2020.
- Shevchenko KV, V'iunova TV, Nagaev IIu, et al. [Proteolysis of simple glyprolines by leucine aminopeptidase and enzymes from nasal slime, brain membranes, and rat blood]. Bioorg Khim. 2013.
Frequently Asked Questions
Is semax nasal spray FDA-approved?
No. The FDA has not reviewed or approved any semax product. The interim peptide policy only outlines when the agency will exercise enforcement discretion for compounding; it is not the same as approval.
What does semax taste or smell like?
Users typically describe a mild saline taste and no strong odor. Individual compounded products may differ depending on the pharmacy’s formulation.
How quickly does semax reach the brain after nasal delivery?
Animal studies indicate peak cerebrospinal fluid levels within 15-30 minutes, but no equivalent human PK study has been published, so timing in people is uncertain.
Can I import Russian semax nose drops for personal use?
Personal drug importation is generally illegal in the United States. Customs may seize unapproved medications, and purity cannot be verified. A safer path is a U.S. prescription and 503A compounding.
Will insurance cover a compounded semax prescription?
Most insurers do not cover non-FDA-approved compounded peptides. Patients typically pay out of pocket, but you can ask your plan about “medical exception” appeals.
How is semax different from selank?
Semax derives from ACTH, while selank is a tuftsin analog. Both are nasal peptide nootropics studied in Russia, but they bind different receptors and have distinct proposed effects.
Are there any drug interactions known with semax?
No systematic interaction studies exist. Out of caution, disclose all medications and supplements to your prescribing clinician.
What storage conditions does semax require?
Russian product labeling advises refrigeration at 36-46 °F (2-8 °C) and protection from light. Your compounding pharmacy will include exact instructions.
